Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
NA
ID: ALA3780630
Max Phase: Preclinical
Molecule Type: Unknown
Associated Items:
This compound is not in our inventory system
ID: ALA3780630
Max Phase: Preclinical
Molecule Type: Unknown
Associated Items:
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
1. Tang ML, Zhou L, Chang J, Hu ZH, Qin Y, Sun X.. (2016) Differential metabolism of 3FDT and docetaxel in RLMs, rats, and HLMs., 113 [PMID:26922231] [10.1016/j.ejmech.2016.02.007] |
Source(1):